Previous 10 |
Aratana Therapeutics (NASDAQ: PETX ): Q4 GAAP EPS of -$0.18. More news on: Aratana Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
LEAWOOD, Kan. , March 12, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, announced its fourth quarter and full year 2018 financial results and re...
LEAWOOD, Kan. , Feb. 12, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Tuesday, March 12, 2019 at 4:30 p....
Aratana Therapeutics (NASDAQ: PETX ) appoints Rhonda Hellums as Chief Financial Officer (CFO) and Treasurer effective February 1. More news on: Aratana Therapeutics, Healthcare stocks news, Read more ...
LEAWOOD, Kan. , Feb. 4, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the appointment of Rhonda Hellums as Chief Financial Off...
Aratana suffered a 26.55% decline on Friday, January 11th, as a downgrade from Stifel ( Aratana down 27% as Stifel softens view ) was said to have prompted the selloff. Perhaps more impactful, was the 13D filing which showed Engaged Capital has reduced their position to roughly 4.1% shares o...
NEW YORK, Jan. 25, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Immunomedics, Inc. (NASDAQ:IMMU), Diamondrock Hospitality Company (NYSE:D...
News, Short Squeeze, Breakout and More Instantly...
Aratana Therapeutics Inc. Company Name:
PETX Stock Symbol:
NASDAQ Market:
Aratana Therapeutics Inc. Website:
LEAWOOD, Kan. , July 16, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and vote...
TÜBINGEN, Germany and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that Timothy Wright, M.D. and Craig Tooman were elected as independent directors to CureVac’s Supervisory ...
LEAWOOD, Kan. , June 11, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food and Drug Administration's Center for Veteri...